CCCC Competitors & Alternatives
Compare C4 Therapeutics Inc with similar stocks in the same industry
Biotechnology
CCCC
Main Stock$4.22
Tradestie Score
60
Market Cap
$153.02M
Revenue Growth
-0.2%
Analyst Upside
+216.0%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.16
|
$512.39M | - | 57 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$35.61
|
$505.12M | 1.9 | 64 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$92.91
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.95
|
$474.20M | 26.8 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$7.41
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$20.71
|
$463.20M | - | 56 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$8.79
|
$457.09M | - | 62 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$5.37
|
$454.29M | - | 57 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$21.22
|
$448.32M | - | 65 | Compare |
More CCCC Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
227 stocks in this industry